16
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Silencing of HJURP induces dysregulation of cell cycle and ROS metabolism in bladder cancer cells via PPARγ-SIRT1 feedback loop

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Holliday Junction Recognition Protein (HJURP) is a centromeric histone chaperone involving in de novo histone H3 variant CenH3 (CENP-A) recruitment. Our transcriptome and in vivo study revealed that HJURP is significantly upregulated in bladder cancer (BCa) tissues at both mRNA and protein levels. Knockdown of HJURP inhibited proliferation and viability of BCa cell lines revealed by CCK-8, colony formation and Ki-67-staining assays, and induced apoptosis and reactive oxygen species (ROS) production, as well as triggered cell cycle arrest at G0/G1 phase possibly via loss of CENP-A. Interestingly, in the HJURP-reduced BCa cells the levels of PPARγ and acetylated-p53 were increased, while the ratio of phosphorylated/total SIRT1 protein was decreased. Moreover, after treatment of the BCa cells using PPARγ antagonist (GW9662) and SIRT1 agonist (resveratrol, RSV) respectively, thee phenotypes of cell cycle arrest, increased ROS production and inhibited proliferation rate were all rescued. Taken together, our results suggested that HJURP might regulate proliferation and apoptosis via the PPARγ-SIRT1 negative feedback loop in BCa cells.

          Related collections

          Most cited references50

          • Record: found
          • Abstract: found
          • Article: not found

          DAVID: Database for Annotation, Visualization, and Integrated Discovery.

          Functional annotation of differentially expressed genes is a necessary and critical step in the analysis of microarray data. The distributed nature of biological knowledge frequently requires researchers to navigate through numerous web-accessible databases gathering information one gene at a time. A more judicious approach is to provide query-based access to an integrated database that disseminates biologically rich information across large datasets and displays graphic summaries of functional information. Database for Annotation, Visualization, and Integrated Discovery (DAVID; http://www.david.niaid.nih.gov) addresses this need via four web-based analysis modules: 1) Annotation Tool - rapidly appends descriptive data from several public databases to lists of genes; 2) GoCharts - assigns genes to Gene Ontology functional categories based on user selected classifications and term specificity level; 3) KeggCharts - assigns genes to KEGG metabolic processes and enables users to view genes in the context of biochemical pathway maps; and 4) DomainCharts - groups genes according to PFAM conserved protein domains. Analysis results and graphical displays remain dynamically linked to primary data and external data repositories, thereby furnishing in-depth as well as broad-based data coverage. The functionality provided by DAVID accelerates the analysis of genome-scale datasets by facilitating the transition from data collection to biological meaning.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Mammalian sirtuins: biological insights and disease relevance.

            Aging is accompanied by a decline in the healthy function of multiple organ systems, leading to increased incidence and mortality from diseases such as type II diabetes mellitus, neurodegenerative diseases, cancer, and cardiovascular disease. Historically, researchers have focused on investigating individual pathways in isolated organs as a strategy to identify the root cause of a disease, with hopes of designing better drugs. Studies of aging in yeast led to the discovery of a family of conserved enzymes known as the sirtuins, which affect multiple pathways that increase the life span and the overall health of organisms. Since the discovery of the first known mammalian sirtuin, SIRT1, 10 years ago, there have been major advances in our understanding of the enzymology of sirtuins, their regulation, and their ability to broadly improve mammalian physiology and health span. This review summarizes and discusses the advances of the past decade and the challenges that will confront the field in the coming years.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              The mechanisms of action of PPARs.

              The peroxisome proliferator-activated receptors (PPARs) are a group of three nuclear receptor isoforms, PPAR gamma, PPAR alpha, and PPAR delta, encoded by different genes. PPARs are ligand-regulated transcription factors that control gene expression by binding to specific response elements (PPREs) within promoters. PPARs bind as heterodimers with a retinoid X receptor and, upon binding agonist, interact with cofactors such that the rate of transcription initiation is increased. The PPARs play a critical physiological role as lipid sensors and regulators of lipid metabolism. Fatty acids and eicosanoids have been identified as natural ligands for the PPARs. More potent synthetic PPAR ligands, including the fibrates and thiazolidinediones, have proven effective in the treatment of dyslipidemia and diabetes. Use of such ligands has allowed researchers to unveil many potential roles for the PPARs in pathological states including atherosclerosis, inflammation, cancer, infertility, and demyelination. Here, we present the current state of knowledge regarding the molecular mechanisms of PPAR action and the involvement of the PPARs in the etiology and treatment of several chronic diseases.
                Bookmark

                Author and article information

                Journal
                J Cancer
                J Cancer
                jca
                Journal of Cancer
                Ivyspring International Publisher (Sydney )
                1837-9664
                2017
                20 July 2017
                : 8
                : 12
                : 2282-2295
                Affiliations
                [1 ]Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan, China;
                [2 ]Department of Urology, The Fifth Hospital of Wuhan, Wuhan, China;
                [3 ]Department of Endocrinology, The First Affiliated Hospital of Zhejiang University, Hangzhou, China;
                [4 ]Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China.
                [5 ]Greenebaum Cancer Center, School of Medicine, University of Maryland, Baltimore, MD, USA.
                [6 ]Medical Research Institute, School of Medicine, Wuhan University, Wuhan, China;
                [7 ]College of Life Science, Wuhan University, Wuhan, China.
                [8 ]Department of Urology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
                [9 ]Department of Biological Repositories, Zhongnan Hospital of Wuhan University, Wuhan, China.
                Author notes
                ✉ Corresponding author: Dr. Xinghuan Wang, Email: wangxinghuan@ 123456whu.edu.cn , Tel. +86-27-6781-3104, Fax: +86-27-6781-2892; and Dr. Yu Xiao, Email: yu.xiao@ 123456whu.edu.cn , Tel. +86-27-6781-2689, Fax: +86-27-6781-2892.

                Competing Interests: The authors declare no competing interests.

                Article
                jcav08p2282
                10.7150/jca.19967
                5560147
                28819432
                e9ab2e73-1625-4cb5-a01b-305978736352
                © Ivyspring International Publisher

                This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license ( https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.

                History
                : 7 March 2017
                : 10 May 2017
                Categories
                Research Paper

                Oncology & Radiotherapy
                bladder cancer,hjurp,cell cycle,ros,pparγ,sirt1
                Oncology & Radiotherapy
                bladder cancer, hjurp, cell cycle, ros, pparγ, sirt1

                Comments

                Comment on this article